Therapy Areas: AIDS & HIV
5 September 2022 - Simcere Pharmaceutical Group (2096.HK), a China-based pharmaceutical company, announced on Monday that it has named Tamas Oravecz, PhD as its new senior vice president, chief scient...
23 August 2022 - - The European Commission has granted Marketing Authorization for Sunlenca (lenacapavir) injection and tablets for the treatment of HIV infection, in combination with other antir...
17 August 2022 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has forged a new health equity collaboration with the Satcher Health Leadership Institute at Morehouse School...
29 July 2022 - - UK-based ViiV Healthcare, the global specialist HIV company majority owned by British pharmaceutical company GSK (NYSE: GSK), with US-based Pfizer (NYSE: PFE) and Japan-based Shionogi...
29 July 2022 - - The FDA accepted for review a Biologics License Application from US-based clinical-stage biotechnology company ImmunityBio, Inc. (NASDAQ: IBRX), for its antibody cytokine fusion prote...
29 July 2022 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has posted results reinforcing Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 m...
Related Headlines